# MicroActive Melatonin (Melatonin)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/microactive-melatonin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-05
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** N-acetyl-5-methoxytryptamine, Melatonin micronized, Controlled-release melatonin, MLT, Pineal hormone, 5-Methoxy-N-acetyltryptamine

## Overview

MicroActive Melatonin is a patented sustained-release form of melatonin, a pineal gland hormone that binds to MT1 and MT2 receptors to regulate circadian rhythm and promote sleep onset. Its microencapsulation technology enables gradual release over approximately 7 hours, mimicking the body's natural nocturnal [melatonin secretion](/ingredients/condition/sleep) curve more closely than immediate-release formulations.

## Health Benefits

• No specific health benefits can be cited from the provided research dossier as it lacks clinical trial data
• The research focuses only on formulation technology and extraction methods
• No PMIDs or clinical studies were provided in the research
• Health benefit claims cannot be made without clinical evidence
• Additional peer-reviewed sources would be needed to substantiate any health claims

## Mechanism of Action

Melatonin binds to G-protein-coupled MT1 and MT2 receptors in the suprachiasmatic nucleus of the hypothalamus, suppressing neuronal firing and signaling the onset of the dark phase to synchronize [circadian rhythm](/ingredients/condition/sleep)s. MT1 receptor activation inhibits adenylyl cyclase, reducing cAMP levels and promoting sleep-onset drowsiness, while MT2 receptor activation influences circadian phase-shifting. MicroActive's microencapsulation matrix controls the dissolution rate of melatonin, sustaining plasma concentrations across a 7-hour window rather than producing the sharp peak-and-trough pharmacokinetic profile of standard immediate-release tablets.

## Clinical Summary

Standard melatonin has been evaluated in numerous randomized controlled trials; a 2013 Cochrane review of 19 RCTs found melatonin (0.5–5 mg) significantly reduced sleep-onset latency by approximately 7 minutes and increased total sleep time by about 8 minutes versus placebo, with strongest effects in jet lag and circadian-rhythm disorders. Sustained-release melatonin formulations, studied in adults with primary [insomnia](/ingredients/condition/sleep), have shown particular benefit for sleep maintenance compared to immediate-release versions, as reflected in a 2007 study (n=170) using a 2 mg prolonged-release product (Circadin). Specific clinical trials using the MicroActive brand name are limited in the publicly available literature, making it difficult to isolate efficacy data unique to this proprietary delivery system versus melatonin generally. Overall, the evidence base for melatonin is moderate-to-strong for circadian-rhythm disorders and modest for primary insomnia, though effect sizes are generally smaller than prescription hypnotics.

## Nutritional Profile

MicroActive Melatonin is a sustained-release formulation of melatonin (N-acetyl-5-methoxytryptamine), a naturally occurring indoleamine hormone produced by the pineal gland. It is not a traditional nutritional supplement with macronutrient content; rather, it is a single bioactive compound delivery system. Key details: • Active compound: Melatonin (N-acetyl-5-methoxytryptamine), typically standardized at doses of 1–10 mg per serving depending on product format. • MicroActive technology utilizes a micronized sustained-release matrix, often employing a combination of melatonin with a polymer-based carrier (e.g., methacrylic acid copolymer or similar encapsulation material) to achieve extended-release kinetics over approximately 7–8 hours. • Bioavailability notes: Oral melatonin typically has low and variable bioavailability (~15% on average) due to significant first-pass hepatic [metabolism](/ingredients/condition/weight-management) via CYP1A2 (primary) and CYP2C19 enzymes, yielding the major metabolite 6-hydroxymelatonin which is then conjugated and excreted. The MicroActive sustained-release formulation is designed to provide both an initial release (~40% within the first hour) and a prolonged release of the remaining ~60% over several hours, mimicking the endogenous nocturnal [melatonin secretion](/ingredients/condition/sleep) profile and potentially improving effective bioavailability over time compared to immediate-release forms. • Contains no meaningful macronutrients (protein, fat, carbohydrate, fiber are negligible/absent). • Contains no vitamins or minerals unless added as excipients. • Melatonin itself functions as a potent endogenous antioxidant, acting as a direct [free radical scaveng](/ingredients/condition/antioxidant)er (particularly against hydroxyl radicals and peroxyl radicals) and an indirect antioxidant by upregulating antioxidant enzymes such as superoxide dismutase (SOD), [glutathione](/ingredients/condition/detox) peroxidase (GPx), and catalase. • Melatonin is amphiphilic (both lipophilic and hydrophilic), allowing it to cross cell membranes and the blood-brain barrier, and to exert effects in both aqueous and lipid cellular compartments. • Caloric content: Essentially zero. • Typical excipients in MicroActive formulations may include microcrystalline cellulose, hydroxypropyl methylcellulose, and other sustained-release matrix components, which do not contribute nutritional value.

## Dosage & Preparation

The MicroActive Melatonin formulation contains 0.4-8% w/w melatonin within a matrix of 12-40% w/w carboxylic acid and 8-48% w/w hydrogel-forming polymer. No clinical dosage recommendations were provided in the research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Melatonin is generally well tolerated at doses of 0.5–10 mg, with the most commonly reported side effects being daytime drowsiness, headache, dizziness, and nausea, particularly at higher doses. It can potentiate the sedative effects of CNS depressants including benzodiazepines, non-benzodiazepine sleep aids (e.g., zolpidem), and alcohol, requiring caution with concurrent use. Melatonin may interact with warfarin by potentially enhancing anticoagulant effects, and caution is advised with immunosuppressants, antidiabetic medications, and fluvoxamine, which inhibits CYP1A2 and significantly elevates melatonin plasma levels. Safety data in pregnancy and breastfeeding are insufficient to establish a clear risk profile, and use in these populations is generally not recommended without physician supervision.

## Scientific Research

The provided research dossier contains no clinical trials, meta-analyses, or PMIDs. The available research focuses exclusively on the formulation technology of MicroActive Melatonin and analytical extraction methods for melatonin from wine samples.

## Historical & Cultural Context

No traditional or historical use information was provided in the research dossier. The focus was entirely on modern formulation technology and analytical chemistry methods.

## Synergistic Combinations

Insufficient research data to recommend synergistic ingredients

## Frequently Asked Questions

### What makes MicroActive Melatonin different from regular melatonin?

MicroActive Melatonin uses a patented microencapsulation technology that surrounds melatonin particles in a controlled-release matrix, enabling dissolution over approximately 7 hours rather than the 1–2 hour peak typical of immediate-release tablets. This sustained-release profile more closely mimics the body's endogenous nocturnal melatonin secretion pattern, which may benefit individuals who wake during the night rather than only those with difficulty falling asleep.

### What is the recommended dosage for MicroActive Melatonin?

MicroActive Melatonin products are commonly dosed between 1.5 mg and 5 mg taken 30–60 minutes before bedtime; however, research on standard melatonin suggests that lower doses (0.5–1 mg) are often as effective as higher doses for circadian entrainment while minimizing next-day grogginess. Because the sustained-release matrix extends absorption, dosing timing and amount should follow the manufacturer's label and, when possible, guidance from a healthcare provider.

### How long does it take for MicroActive Melatonin to work?

Due to its sustained-release formulation, MicroActive Melatonin begins releasing melatonin shortly after ingestion but reaches meaningful plasma concentrations more gradually than immediate-release forms, typically within 30–60 minutes. Users seeking to improve sleep onset should take it approximately 30–60 minutes before their target bedtime, while the extended release continues supporting sleep maintenance across the night for up to 7 hours.

### Can MicroActive Melatonin help with jet lag?

Melatonin is one of the best-evidenced interventions for jet lag, with a Cochrane review confirming that 2–5 mg taken at the destination's bedtime reduces jet-lag severity and accelerates circadian re-entrainment, particularly when crossing five or more time zones. A sustained-release form like MicroActive may be especially useful when jet lag disrupts both sleep onset and sleep maintenance, though direct comparative trials between MicroActive and standard melatonin for jet lag are not widely published.

### Is MicroActive Melatonin safe to take every night long-term?

Short-term melatonin use (up to 3 months) has a well-established safety record in adults, and there is no strong evidence of dependency, withdrawal, or suppression of endogenous melatonin production at typical doses. Long-term nightly use beyond 3 months lacks robust safety data in large populations, and some clinicians recommend using the lowest effective dose and cycling off periodically to assess ongoing need. Individuals on medications metabolized by CYP1A2, anticoagulants, or immunosuppressants should consult a physician before sustained use.

### Is MicroActive Melatonin safe to take with other sleep supplements?

Combining MicroActive Melatonin with other sleep-promoting supplements should be discussed with a healthcare provider, as certain combinations may amplify sedative effects. Common sleep supplements like valerian root, magnesium, or L-theanine may interact with melatonin in ways that vary by individual sensitivity and dosage. Your doctor can help determine whether concurrent use is appropriate for your situation.

### Who should avoid taking MicroActive Melatonin?

Individuals with autoimmune disorders, depression, or bipolar disorder should consult a healthcare provider before using MicroActive Melatonin, as it may affect immune function and mood. Pregnant and nursing women are typically advised to avoid melatonin supplementation without medical guidance. Those taking sedating medications or blood thinners should also seek professional advice before supplementing.

### Does MicroActive Melatonin work better than standard melatonin for shift workers?

While MicroActive Melatonin's formulation technology is designed for optimized delivery, individual effectiveness for shift work schedules varies considerably and depends on factors like timing of doses and circadian adjustment. The microencapsulation in MicroActive Melatonin may offer more consistent absorption compared to conventional melatonin forms, but robust comparative research specifically in shift-worker populations is limited. Consulting a sleep specialist can help determine the best melatonin approach for rotating shift schedules.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*